Results 231 to 240 of about 241,277 (303)
Genomic and transcriptomic landscape of carcinogenesis in patients with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). [PDF]
Matsumoto C +16 more
europepmc +1 more source
ABSTRACT Despite the transformative impact of cancer immunotherapies such as immune checkpoint blockade, durable clinical responses remain limited. Increasing evidence indicates that antitumor immunity is governed not only by the tumor microenvironment, but also by systemic immune regulation mediated by peripheral immune organs. Among these, the spleen
Yuehua Liu, Xiaoqian Nie, Xiaofei Gao
wiley +1 more source
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance. [PDF]
White M +40 more
europepmc +1 more source
ABSTRACT Hepatocellular carcinoma (HCC) remains a significant clinical challenge due to the limited efficacy of conventional treatments like surgery, radiofrequency ablation (RFA), and transarterial embolization (TAE). Here, we develop an innovative TAE and immunothermal therapy strategy based on smartly assembled near‐micron layered double hydroxide ...
Qitao Hu +12 more
wiley +1 more source
The use of whole genome sequencing to study young patients with 100+ adenomas of the colon. [PDF]
Tsukanov AS +7 more
europepmc +1 more source
CDK5RAP2 associates with the kinesin HSET and forms co‐condensates. HSET motors drive the directional transport of CDK5RAP2 condensates toward microtubule minus ends. During mitosis, HSET self‐assembly further stabilizes clustered centrosomes, thereby enabling pseudo‐bipolar spindle formation in cancer cells with supernumerary centrosomes. Upon mitotic
Po‐Pang Chen +11 more
wiley +1 more source
Metastatic colorectal adenocarcinoma with APC and EGFR L858R co-mutations: a case report. [PDF]
Cavalheiro VJ +9 more
europepmc +1 more source
Characterization of Korean Colorectal Cancer Reveals Novel Driver Gene and Clinically Relevant Mutations. [PDF]
Kang J +29 more
europepmc +1 more source
Ubiquitylation-oxaliplatin-related prognosis signature reveals the landscapes of immune responses, cell communication, and therapeutic sensitivity for colorectal cancer. [PDF]
Zhang G, Chen X.
europepmc +1 more source

